We are live on ! Find out more
BCM

Bayesian Capital Management Portfolio holdings

AUM $81.9M
1-Year Est. Return 26.59%
This Fund
S&P 500
This Quarter Est. Return
-1.32%
1 Year Est. Return
+26.59%
3 Year Est. Return
+112.98%
5 Year Est. Return
+129.77%
10 Year Est. Return
+1,146.62%
AUM
$493M
AUM Growth
-$43.7M
Cap. Flow
-$6.65M
Cap. Flow %
-1.35%
Top 10 Hldgs %
14.21%
Holding
1,115
New
370
Increased
135
Reduced
155
Closed
453

Top Sells

Rank Stock Value
1
TFC icon
Truist Financial
TFC
+$6.76M
2
QCOM icon
Qualcomm
QCOM
+$6.11M
3
WBA
Walgreens Boots Alliance
WBA
+$4.04M
4
EOG icon
EOG Resources
EOG
+$4.02M
5
TMUS icon
T-Mobile US
TMUS
+$3.82M

Sector Composition

Rank Sector Weight
1 Technology 24.08%
2 Healthcare 13.66%
3 Consumer Discretionary 12.3%
4 Industrials 9.83%
5 Financials 9.02%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MAR icon
176
Marriott International
MAR
$101B
$778K 0.16%
5,551
-3,265
-37% -$499K
XRT icon
177
State Street SPDR S&P Retail ETF
XRT
$448M
$778K 0.16%
13,782
+8,082
+142% +$516K
NFE icon
178
New Fortress Energy
NFE
$96.4M
$774K 0.16%
+17,700
New +$888K
ARRY icon
179
Array Technologies
ARRY
$848M
$771K 0.16%
46,476
+702
+2% +$12.1K
VLO icon
180
Valero Energy
VLO
$90.5B
$769K 0.16%
+7,200
New +$792K
CUZ icon
181
Cousins Properties
CUZ
$5.28B
$761K 0.15%
32,600
+22,900
+236% +$647K
COOP
182
DELISTED
Mr. Cooper
COOP
$759K 0.15%
18,743
+4,100
+28% +$173K
NATI
183
DELISTED
National Instruments Corp
NATI
$759K 0.15%
+20,100
New +$760K
BLUE
184
DELISTED
bluebird bio
BLUE
$757K 0.15%
+5,980
New +$677K
SU icon
185
Suncor Energy
SU
$75.6B
$752K 0.15%
26,700
-6,300
-19% -$199K
JAZZ icon
186
Jazz Pharmaceuticals
JAZZ
$16B
$745K 0.15%
+5,588
New +$850K
EVH icon
187
Evolent Health
EVH
$429M
$736K 0.15%
+20,489
New +$722K
CCEP icon
188
Coca-Cola Europacific Partners
CCEP
$48.1B
$733K 0.15%
17,201
+6,501
+61% +$327K
XP icon
189
XP
XP
$8.65B
$732K 0.15%
38,500
+26,000
+208% +$516K
BLD
190
DELISTED
TopBuild
BLD
$731K 0.15%
+4,435
New +$820K
RPD icon
191
Rapid7
RPD
$643M
$729K 0.15%
+16,986
New +$1.05M
SHOP icon
192
Shopify
SHOP
$165B
$728K 0.15%
+27,010
New +$919K
SYF icon
193
Synchrony
SYF
$24.5B
$724K 0.15%
25,687
-15,400
-37% -$497K
TTD icon
194
Trade Desk
TTD
$8.41B
$723K 0.15%
12,100
-36,600
-75% -$2.08M
FRC
195
DELISTED
First Republic Bank
FRC
$711K 0.14%
5,446
+4,000
+277% +$614K
CVE icon
196
Cenovus Energy
CVE
$52.3B
$710K 0.14%
+46,200
New +$821K
DHI icon
197
D.R. Horton
DHI
$41.3B
$709K 0.14%
+10,522
New +$774K
HOG icon
198
Harley-Davidson
HOG
$2.61B
$704K 0.14%
+20,172
New +$758K
QLYS icon
199
Qualys
QLYS
$4.75B
$704K 0.14%
5,049
-700
-12% -$98.6K
TOST icon
200
Toast
TOST
$17.9B
$696K 0.14%
41,627
+16,600
+66% +$288K

Similar funds

Bayesian Capital Management's Q3 2022 Portfolio in Review

As of Q3 2022, Bayesian Capital Management held 1,115 positions worth $493M, down 8.1% from $537M the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Bayesian Capital Management's Q3 2022 filing shows 370 new, 135 increased, 155 reduced and 453 closed positions. Its largest new stake was State Street SPDR S&P 500 ETF Trust: 39,700 shares worth $14.2M. The largest sale was Truist Financial, an estimated $6.76M.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 21% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Bayesian Capital Management's largest Q3 2022 buy was State Street SPDR S&P 500 ETF Trust: 39,700 shares worth $14.2M.
  • Bayesian Capital Management added most to Medtronic in Q3 2022, an estimated $7.24M increase.
  • Bayesian Capital Management's biggest Q3 2022 reduction was Truist Financial, cutting an estimated $6.76M.
  • Bayesian Capital Management fully exited Walgreens Boots Alliance in Q3 2022, selling an estimated $4.04M.
  • Bayesian Capital Management's ten largest holdings make up 14% of its $493M portfolio in Q3 2022.
  • Bayesian Capital Management opened 370 new positions and closed 453 in Q3 2022.
  • Bayesian Capital Management's portfolio value fell 8.1% quarter-over-quarter to $493M.

Based on Bayesian Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.